Bullishcharts

$REGN Regeneron, Wait for better entry

NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.

REGN making some moves in the pre-market, but
care needed on rash entries.
Multiple resistance factors to cross before risk \ reward improves.
50 & 100ma's
2015 pivot point @ $605

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。